WallStreetZenWallStreetZen

NASDAQ: GYRE
Gyre Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their GYRE stock forecasts and price targets.

Forecast return on equity

Is GYRE forecast to generate an efficient return?
Company
N/A
Industry
-781%
Market
49.42%

Forecast return on assets

Is GYRE forecast to generate an efficient return on assets?
Company
N/A
Industry
25.95%

GYRE earnings per share forecast

What is GYRE's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.45
Avg 2 year Forecast
-$0.30

GYRE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GYRE$13.34N/AN/A
INVA$19.89N/AN/A
PRAX$70.04$146.13+108.63%Strong Buy
COGT$11.31$14.83+31.15%Buy
DAWN$14.30$34.60+141.96%Strong Buy
View Top Biotech Stocks

Gyre Therapeutics Stock Forecast FAQ

What is GYRE's earnings growth forecast for 2024-2025?

(NASDAQ: GYRE) Gyre Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.51%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.85%.

Gyre Therapeutics's earnings in 2024 is -$79,661,000.On average, 1 Wall Street analyst forecast GYRE's earnings for 2024 to be -$42,040,883, with the lowest GYRE earnings forecast at -$42,040,883, and the highest GYRE earnings forecast at -$42,040,883.

In 2025, GYRE is forecast to generate -$28,027,255 in earnings, with the lowest earnings forecast at -$28,027,255 and the highest earnings forecast at -$28,027,255.

If you're new to stock investing, here's how to buy Gyre Therapeutics stock.

What is GYRE's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: GYRE) forecast ROE is N/A, which is considered weak.

What is GYRE's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: GYRE) Gyre Therapeutics's current Earnings Per Share (EPS) is -$0.38. On average, analysts forecast that GYRE's EPS will be -$0.45 for 2024, with the lowest EPS forecast at -$0.45, and the highest EPS forecast at -$0.45. In 2025, GYRE's EPS is forecast to hit -$0.30 (min: -$0.30, max: -$0.30).

What is GYRE's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: GYRE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 25.95%.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.